News
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...
Barclays lowered the firm’s price target on Novo Nordisk (NVO) to DKK 700 from DKK 900 and keeps an Overweight rating on the shares.Stay Ahead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results